The Impact of COVID-19 on the Dermatologic Healthcare Community

The COVID-19 pandemic has proven widespread, global effects which span further than just the immense death rates from country to country. As the infection and mortality numbers continue to increase, clinicians worldwide must still evaluate, diagnose, and treat patients for all medical issues whether those issues are related to COVID-19 or not. Along with its …

Psoriasis and Its Treatment with New Generation Biologics

By: Sangeeta Chakraborty, Ph.D. | Research Associate at National Jewish Health Overview Psoriasis is one of the most common non-communicable skin disorders with a worldwide prevalence of about 2% but can vary from 0.5 to 11%, depending on the geographic region. Since psoriasis pathogenesis is quite complex and the exact mechanisms of its cause are …

Atopic Dermatitis: Therapeutic Treatment Options

Atopic dermatitis, or eczema, is a skin condition that affects approximately 30 percent of people in the United States: most of whom are children and adolescents. A person with eczema will typically experience patches of dry, itchy skin that may crack, bleed, or become infected. Multiple factors can trigger or worsen atopic dermatitis, including low humidity, …